Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 4, 1999, Pages 262-271

  Bock, Christina ^a   Niederhoffer, Nathalie ^a   Szabo, Bela ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Blood pressure; Imidazoline receptor; Moxonidine; Rilmenidine; Rostral ventrolateral medulla oblongata; Sympathoinhibition; Methyldopa; 2 Adrenoceptor

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPINE; EFAROXAN; METHYLDOPA; MOXONIDINE; RILMENIDINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG ACTIVATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; INTRACISTERNAL DRUG ADMINISTRATION; MALE; NONHUMAN; RABBIT; RAT; RECEPTOR AFFINITY; XEROSTOMIA;

EID: 0032899494     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005351     Document Type: Article

References (48)

1. Badoer E, Head GA, Korner PI (1983) Effects of intracisternal and intravenous α-methyldopa and clonidine on haemodynamics and baroreceptor-heart rate reflex properties in conscious rabbits. J Cardiovasc Pharmacol 5:760-767
2. 3H]-clonidine to identify imidazoline receptors in the rabbit brainstem. Br J Pharmacol 110:1537-1543
3. 3H]clonidine. Eur J Pharmacol 266:25-33
4. 1-adrenoceptor agonist-induced responses by rilmenidine in vascular smooth muscle. Eur J Pharmacol 341:179-185
5. Chan CKS, Sannajust F, Head GA (1996) Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. J Pharmacol Exp Ther 276:411-420
6. Dampney RAL (1994) The subretrofacial vasomotor nucleus: Anatomical, chemical and pharmacological properties and role in cardiovascular regulation. Prog Neurobiol 42:197-227
7. Duggan S, Hong M, Milne B, Jhamandas K (1994) The role of excitatory amino acids in the expression of precipitated acute and chronic clonidine withdrawal: An in vivo voltammetric study in the rat locus coeruleus. Brain Res 665:253-261
8. Eglen RM, Hudson AL, Kendall DA, Nutt DJ, Morgan NG, Wilson VG, Dillon MP (1998) "Seeing through a glass darkly": Casting light on imidazoline "I" sites. Trends Pharmacol Sci 19:381-390
9. 1-imidazoline binding site is a functional receptor mediating vasodepression via the ventral medulla. Am J Physiol 273:R1572-R1579
10. 2-adrenoceptors in the ventrolateral medulla. Eur J Pharmacol 134:1-13
11. Ernsberger P, Giuliano R, Willette RN, Reis DJ (1990) Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J Pharmacol Exp Ther 253:408-418
12. 1-imidazoline sites. J Pharmacol Exp Ther 264:172-182
13. Feldman J, Tibiriça E, Bricca G, Dontenwill M, Belcourt A, Bousquet P (1990) Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br J Pharmacol 100:600-604
14. Fillastre J-P, Letac B, Galinier F, Le Bihan G, Schwartz J (1988) A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients. Am J Cardiol 61:81D-85D
15. Gomez RE, Ernsberger P, Feinland G, Reis DJ (1991) Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur J Pharmacol 195:181-191
16. Gutkind JS, Kazanietz M, Enero MA (1986) Cardiovascular effects of alpha-adrenergic drugs: Differences between clonidine and guanabenz. Naunyn Schmiedebergs Arch Pharmacol 332:370-375
17. Guyenet PG (1997) Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites? Am J Physiol 273:R1580-R1584
18. Hall S, Milne B, Jhamandas K (1996) Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: An in vivo voltammetric study. Brain Res 739:182-191
19. Hamilton CA, Yakubu MA, Jardine E, Reid JL (1991) Imidazole binding sites in rabbit kidney and forebrain membranes. J Auton Pharmacol 11:277-283
20. 1-imidazoline receptors in the rostral ventrolateral medulla. J Cardiovasc Pharmacol 24 [Suppl I]:S1-S8
21. 2-adrenoceptors. Br J Pharmacol 110:1635-1639
22. Kobinger W (1978) Central α-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81:39-100
23. Kobinger W, Pichler L (1990) Centrally acting drugs (clonidine, methyldopa, guanfacine). In: Born GVR, Cuatrecasas P, Herken H (eds) Handbook of Experimental Pharmacology, Vol 93. Pharmacology of Antihypertensive Therapeutics. Springer, Berlin Heidelberg New York, pp 227-262
24. Laurent S, Safar M (1992) Rilmenidine: A novel approach to first-line treatment of hypertension. Am J Hypertens 5:99S-105S
25. 2A-adrenergic receptor subtype. Science 273:801-803
26. Mayorov D, Chernobelski M, Medvedev O (1993) Sympathoinhibitory action of rilmenidine in conscious sinoaortically denervated rats. J Cardiovasc Pharmacol 22:314-320
27. Molderings GJ (1997) Imidazoline receptors: Basic knowledge, recent advances and future prospects for therapy and diagnosis. Drugs Future 22:757-772
28. 1-imidazoline sites in bovine adrenal medullary membranes. Naunyn Schmiedebergs Arch Pharmacol 348:70-76
29. Munk SA, Lai RK, Burke JE, Arasasingham PN, Kharlamb AB, Manlapaz CA, Padillo EU, Wijono MK, Hasson DW, Wheeler LA, Garst ME (1996) Synthesis and pharamacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: A potent imidazolinel receptor specific agent. J Med Chem 39:1193-1195
30. 1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther 279:694-702
31. Plänitz V (1984) Crossover comparison of moxonidine and clonidine in mild to moderate hypertension. Eur J Clin Pharmacol 27:147-152
32. 2A-adrenergic receptors in catecholaminergic and other brainstem neurons in the rat. Neuroscience 56:139-155
33. Sannajust F, Head GA (1994) Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors. J Cardiovasc Pharmacol 23:42-50
34. Sannajust F, Cerutti C, Koenig-Bérard E, Sassard J (1992) Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats. Br J Pharmacol 105:542-548
35. Sun M-K (1996) Pharmacology of reticulospinal vasomotor neurons in cardiovascular regulation. Pharmacol Rev 48:465-494
36. Szabo B, Schultheiss A (1990) Desipramine inhibits sympathetic nerve activity in the rabbit. Naunyn Schmiedebergs Arch Pharmacol 342:469-476
37. 1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine. Arzneimittelforschung 47:1009-1015
38. 2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 348:593-600
39. Szabo B, Urban R, Limberger N, Starke K (1995) Cardiovascular effects of agmatine, a "clonidine-displacing substance", in conscious rabbits. Naunyn Schmiedebergs Arch Pharmacol 351:268-273
40. Tibiriça E, Feldman J, Bousquet P (1988) Differences in the ability of yohimbine to antagonize the hypotensive effect of clonidine in normotensive and spontaneously hypertensive anesthetized rats. J Pharmacol Exp Ther 244:1062-1066
41. Tibiriça E, Feldman J, Mermet C, Gonon F, Bousquet P (1991) An imidazoline-specific mechanism for the hypotensive effect of clonidine: A study with yohimbine and idazoxan. J Pharmacol Exp Ther 256:606-613
42. Tibiriça E, Feldman J, Bousquet P (1992) Contribution of catecholaminergic neurons of the dorsomedial and ventrolateral medulla oblongata to the hypotensive effect of clonidine in spontaneously hypertensive rats: In vivo voltammetric studies. J Hypertens 10:1327-1334
43. Timmermans PBMWM, Schoop AMC, Kwa HY, Van Zwieten PA (1981) Characterization of α-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine. Eur J Pharmacol 70:7-15
44. Urban R, Szabo B, Starke K (1994) Is the sympathoinhibitory effect of rilmenidine mediated by alpha-2 adrenoceptors or imidazoline receptors? J Pharmacol Exp Ther 270:572-578
45. 2-adrenoceptors in the cardiovascular effects of moxonidine. Eur J Pharmacol 282:19-28
46. Urban R, Szabo B, Starke K (1995b) Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304. Eur J Pharmacol 282:29-37
47. Van Zwieten PA, Thoolen MJMC, Timmermanns PBMWM (1984) The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine. Hypertension 6 [Suppl II]:28-33
48. 2A-AR) mice. Br J Pharmacol 122:70P